<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>ISSCA Members | Site-Wide Activity</title>
	<link>https://members.issca.com/news-feed/</link>
	<atom:link href="https://members.issca.com/news-feed/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the entire site.</description>
	<lastBuildDate>Wed, 10 Jun 2026 00:06:29 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=3.0.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">b861ff2b48c46635d61ee8dc120f694a</guid>
				<title>Fabio Oreste replied to the discussion Patient Câncer in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1511</link>
				<pubDate>Fri, 05 Jun 2026 00:51:00 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1511"><span class="bb-reply-lable">Reply to</span> Patient Câncer</a></p> <div class="bb-content-inr-wrap"><p>Ipamorelin and CJC-1295 are contraindicated in any oncological context — both confirmed diagnosis and clinical suspicion.</p>
<p>Both compounds stimulate pituitary GH release, which in turn drives hepatic IGF-1 synthesis. IGF-1 is a well-characterised mitogen that activates the PI3K/AKT/mTOR and RAS/MAPK proliferative cascades, suppresses apoptosis, and&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2878"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1511" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5cf3e2898d1c02bf4475b9759fed733f</guid>
				<title>Jeruza Campos replied to the discussion Patient Câncer in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1510</link>
				<pubDate>Thu, 04 Jun 2026 21:47:20 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1510"><span class="bb-reply-lable">Reply to</span> Patient Câncer</a></p> <div class="bb-content-inr-wrap"><p>Muito obrigada Audre… Essa era a minha preocupação mas queria saber também outras opiniões! </p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">f2c2b63f14e2ec974c1c5e6e14f62dc7</guid>
				<title>Jeruza Campos replied to the discussion Patient Câncer in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1509</link>
				<pubDate>Thu, 04 Jun 2026 21:45:10 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1509"><span class="bb-reply-lable">Reply to</span> Patient Câncer</a></p> <div class="bb-content-inr-wrap"><p>Thank you very much Andrea. Tomorrow i will meet the patient and request the additional info. </p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c082d3ed4c9b8e96895bb52bd92c6c1c</guid>
				<title>Andrea Lapeire replied to the discussion Patient Câncer in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1508</link>
				<pubDate>Thu, 04 Jun 2026 21:36:14 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1508"><span class="bb-reply-lable">Reply to</span> Patient Câncer</a></p> <div class="bb-content-inr-wrap"><p>Before considering Ipamorelin or CJC-1295, could you please provide additional information regarding the tumor biology, including ER, PR, HER2 status, Ki-67, disease stage, and current chemotherapy regimen?</p>
<p>In general, I am cautious with GH secretagogues such as Ipamorelin and CJC-1295 in patients with active breast cancer, as they may&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2875"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1508" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3e0698cf5edf1388a8e48e3d36545197</guid>
				<title>audrey-nunes Nunes replied to the discussion Patient Câncer in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1507</link>
				<pubDate>Thu, 04 Jun 2026 21:12:52 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/#post-1507"><span class="bb-reply-lable">Reply to</span> Patient Câncer</a></p> <div class="bb-content-inr-wrap"><p>recomendação geral é de não utilizar em pacientes com câncer ativo e ter muita cautela em pacientes com histórico de câncer, principalmente sem liberação do oncologista. Isso ocorre porque o CJC-1295 aumenta a secreção de hormônio do crescimento (GH) e consequentemente pode elevar os níveis de IGF-1.</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">347ae400cd86e4afd70a30426ad2b9fc</guid>
				<title>Jeruza Campos started the discussion Patient Câncer in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/</link>
				<pubDate>Thu, 04 Jun 2026 21:05:42 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/">Patient Câncer</a></p> <div class="bb-content-inr-wrap"><p>Good evening, everyone!</p>
</p>
<p>I have a patient with breast cancer who is still undergoing chemotherapy. She is an athlete and has been responding well to both her medications and treatment.</p>
</p>
<p>In addition to <strong>Thymosin Alpha-1</strong>, would it be reasonable to consider <strong>Ipamorelin</strong> and <strong>CJC-1295</strong> to help maintain body composition and lean muscle mass during&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2873"><a href="https://members.issca.com/groups/issca-community/forum/discussion/patient-cancer/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6896a953701c3733f90f10cb74e1cb11</guid>
				<title>Mario Harms posted an update in the group ISSCA Community: IL-23 inhibitorJNJ-77242113 what would be a safe dose for [&#133;]</title>
				<link>https://members.issca.com/news-feed/p/2851/</link>
				<pubDate>Thu, 28 May 2026 00:15:31 -0500</pubDate>

									<content:encoded><![CDATA[<p>IL-23 inhibitorJNJ-77242113 what would be a safe dose for a weekly subcutaneous injection?</p>
<p>suffers greatly from psoriasis.</p>
<p>have access to lyophilized powder (Icotrokinra/Icotyde) but getting two different kinds of feedback.</p>
<p>one saying it&#8217;s a great idea better absorption way smaller doses required compared to oral.</p>
<p>other advising against it</p>
]]></content:encoded>
				
									<slash:comments>3</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c2092332875b843698be269fc0cfbbfc</guid>
				<title>Nick Duffy replied to the discussion Whats the most underrated tool in regenerative medicine right now? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1387</link>
				<pubDate>Wed, 06 May 2026 10:45:33 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1387"><span class="bb-reply-lable">Reply to</span> Whats the most underrated tool in regenerative medicine right now?</a></p> <div class="bb-content-inr-wrap"><p>Great question, and whilst I can only comment as a transformation and optimisation coach rather than a practitioner, having worked across nutrition, hormones, blood chemistry and peptides for over 10 years I&#8217;ve seen this play out time and time again.</p>
<p>Most people are chasing the headline treatments and ignoring the very thing that makes them&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2543"><a href="https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1387" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">e1652bcbcc5e2e4eeed6dfe86f7c74fe</guid>
				<title>Jeruza Campos posted an update in the group ISSCA Community: Paciente com fratura exposta de tibia após acidente. [&#133;]</title>
				<link>https://members.issca.com/news-feed/p/2512/</link>
				<pubDate>Fri, 01 May 2026 18:01:09 -0500</pubDate>

									<content:encoded><![CDATA[<p>Paciente com fratura exposta de tibia após acidente. Ja  fase de recuperação e agora vamos começar terapia com peptídeos…</p>
<p>Bpc 157 + tb 500 &#8211; dose continua diaria ou dose alta depois diminui?</p>
<p>kpv em que frequência?</p>
<p>Cjc 1295+ Ipamorelin &#8211; para manter massa muscular que ja esta perdendo. Frequência semanal e pausa no fim de semana? </p></p>
]]></content:encoded>
				
									<slash:comments>2</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a4cbda98f71e0ee8ad9e8c8c782bc7e2</guid>
				<title>Enrique Tovar replied to the discussion Whats the most underrated tool in regenerative medicine right now? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1375</link>
				<pubDate>Wed, 29 Apr 2026 20:33:08 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1375"><span class="bb-reply-lable">Reply to</span> Whats the most underrated tool in regenerative medicine right now?</a></p> <div class="bb-content-inr-wrap"><p>Estoy totalmente de acuerdo, tratar el terreno es fundamental</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ec838a4ace1be87c3e877f2350b420f7</guid>
				<title>Hasnain Shah posted an update in the group ISSCA Community: https://www.linkedin.com/in/hasnainhaider1?utm_source=share_v [&#133;]</title>
				<link>https://members.issca.com/news-feed/p/2476/</link>
				<pubDate>Tue, 28 Apr 2026 11:09:51 -0500</pubDate>

									<content:encoded><![CDATA[<p><a target='_blank' href="https://www.linkedin.com/in/hasnainhaider1?utm_source=share_via&#038;utm_content=profile&#038;utm_medium=member_android" rel="nofollow">https://www.linkedin.com/in/hasnainhaider1?utm_source=share_via&#038;utm_content=profile&#038;utm_medium=member_android</a></p>
<p>I wanted to introduce myself to the group. </p>
<p>I am  a  McGill University Medical graduate  with fellowships in Interventional Radiology and Neurointerventional Surgery.</p>
<p></p>
<p> I have extensive training in Interventional Oncology (including all&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2476"><a href="https://members.issca.com/news-feed/p/2476/" rel="nofollow"> Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>2</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3fa30f34205a15c1d9654426359e68ce</guid>
				<title>Roberto Ramón Vallarino replied to the discussion Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1367</link>
				<pubDate>Mon, 27 Apr 2026 19:28:55 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1367"><span class="bb-reply-lable">Reply to</span> Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues.</a></p> <div class="bb-content-inr-wrap"><p>Writing about the progress of our patient, starting this week MSCs IV. Completely off mesalazine and azathioprine. </p>
</p>
<p>Entering cellular therapy with inflammatory markers (CRP, lactoferrin, calprotectin) presenting a significant delta for better. Lower yet there is still a manageable inflamation for homing. </p>
</p>
<p>Patient has reported energy like&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2470"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1367" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b20c00501b81fbbfe953db858b864490</guid>
				<title>Roberto Ramón Vallarino posted an update: </title>
				<link>https://members.issca.com/news-feed/p/2178/</link>
				<pubDate>Tue, 31 Mar 2026 00:23:57 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f48f21a3f7e84df5d0e8c18452bd5331</guid>
				<title>Carlos Arguedas replied to the discussion Caso de vitiligo en paciente femenino 56 años. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/#post-1216</link>
				<pubDate>Sun, 29 Mar 2026 17:23:14 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/#post-1216"><span class="bb-reply-lable">Reply to</span> Caso de vitiligo en paciente femenino 56 años.</a></p> <div class="bb-content-inr-wrap"><p>Muchas gracias por la respuesta doctora. Excelente voy a revisar las recomendaciones. Muy agradecido!!</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a8d35a0e995f1b64e90f4bae01a97461</guid>
				<title>Andrea Lapeire replied to the discussion Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1215</link>
				<pubDate>Sun, 29 Mar 2026 16:46:37 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1215"><span class="bb-reply-lable">Reply to</span> Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues.</a></p> <div class="bb-content-inr-wrap"><p>Excelente plan de abordaje doctor. </p>
<p>Todo lo que presenta la paciente indica Endotoxemia, sería interesante ver su Microbiota y tratar LeakyGut.</p>
<p>Me encantaría saber su evolución</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">04b7e50bffc1268634c3dc0c759243fb</guid>
				<title>Andrea Lapeire replied to the discussion Stem cells vs exosomes in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/#post-1214</link>
				<pubDate>Sun, 29 Mar 2026 16:42:11 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/#post-1214"><span class="bb-reply-lable">Reply to</span> Stem cells vs exosomes</a></p> <div class="bb-content-inr-wrap"><p>Va a depender del paciente que tenga delante. Exosomas son más versátiles, te permiten la modulación previa y actúan ellos mismos también como terapéuticos sobre las stem cell residentes, son pequeños por lo permiten usos más generales, no tienen efecto regenerador o scaffold perse. Células requieren mayor precisión en su uso, tienen efecto&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2170"><a href="https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/#post-1214" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">f3fb1eb3e0cfbd38d0bb0131b1388060</guid>
				<title>Andrea Lapeire replied to the discussion Whats the most underrated tool in regenerative medicine right now? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1213</link>
				<pubDate>Sun, 29 Mar 2026 16:37:55 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1213"><span class="bb-reply-lable">Reply to</span> Whats the most underrated tool in regenerative medicine right now?</a></p> <div class="bb-content-inr-wrap"><p>Exacto&#8230; creer que las terapias regenerativas hacen magia sin tener en cuenta terreno y fisiopatogenia.</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1d0ea93f7fd509cd3f55615c4d512525</guid>
				<title>Andrea Lapeire replied to the discussion Caso de vitiligo en paciente femenino 56 años. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/#post-1212</link>
				<pubDate>Sun, 29 Mar 2026 16:36:21 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/#post-1212"><span class="bb-reply-lable">Reply to</span> Caso de vitiligo en paciente femenino 56 años.</a></p> <div class="bb-content-inr-wrap"><p>Super interesante el caso doc. En esta pcte pensaría en modular muy bien terreno (inmunológica, inflamatorio, metabólico) y sobre todo cual fue el gatillo sistémico reciente (menopausia, Disbiosis, tiroides, Insulina,  Cortisol, etc). Haría un abordaje en tres tiempos:</p>
<p>1- Terreno: NAC, NAD+, omega, Vit. A, E, C, Zn, Se. Algún drip también. </p>
<p>2-&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2168"><a href="https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/#post-1212" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">80aa6dfc22cf39d22eca5910d442666b</guid>
				<title>Carlos Arguedas started the discussion Caso de vitiligo en paciente femenino 56 años. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/</link>
				<pubDate>Sun, 29 Mar 2026 16:07:39 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/">Caso de vitiligo en paciente femenino 56 años.</a></p> <div class="bb-content-inr-wrap"><p>Paciente femenina de 56 años, conocida hipertensa en tratamiento con Ziac 5 mg por día.</p>
<p>Paciente con vitiligo de aproximadamente 5 años. Desde hace un año empeora el cuadro con afectación de manos, codos, pies, cuello, espalda.</p>
<p>Quisiera aportes sobre tratamientos medicina regenerativa y protocolos con peptidos, exosomas, etc.</p>
<p>Muchas gracias.</p>
<p>Dr.&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2167"><a href="https://members.issca.com/groups/issca-community/forum/discussion/caso-de-vitiligo-en-paciente-femenino-56-anos/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">088a2b7086d1d78edfa5a991544dcd51</guid>
				<title>Maria replied to the discussion Whats the most underrated tool in regenerative medicine right now? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1200</link>
				<pubDate>Tue, 24 Mar 2026 19:39:05 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/#post-1200"><span class="bb-reply-lable">Reply to</span> Whats the most underrated tool in regenerative medicine right now?</a></p> <div class="bb-content-inr-wrap"><p>In my opinion, one of the most underrated tools is actually the proper preparation of the biological terrain, including metabolic optimization, gut health, inflammation control, and mitochondrial support. Many practitioners focus on advanced therapies, but without this foundation, results can be limited or inconsistent.</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a7d3e443af1c73de8a09ac005fad35bf</guid>
				<title>Maria replied to the discussion Stem cells vs exosomes in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/#post-1199</link>
				<pubDate>Tue, 24 Mar 2026 19:36:37 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/#post-1199"><span class="bb-reply-lable">Reply to</span> Stem cells vs exosomes</a></p> <div class="bb-content-inr-wrap"><p>Excelente pregunta. En mi opinión médica, la elección depende del objetivo terapéutico y del nivel de intervención biológica que buscamos en cada paciente.</p>
<p>Sumando los péptidos a mi comentario, los exosomas y las células madre no compiten entre sí, sino que cumplen roles biológicos complementarios: los &lt;strong data-start=&#8221;358&#8243;&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2122"><a href="https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/#post-1199" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5ea859b38e5ffa30e49d06034bc4b27d</guid>
				<title>Maria replied to the discussion Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1198</link>
				<pubDate>Tue, 24 Mar 2026 19:07:17 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1198"><span class="bb-reply-lable">Reply to</span> Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues.</a></p> <div class="bb-content-inr-wrap"><p>Thank you for sharing this case, and welcome to the community!</p>
<p>You’re doing a great job managing a very complex patient. It’s encouraging to see her clinical improvement and how structured and thoughtful your approach has been so far.</p>
<p>The issue with lab orders across systems is something many of us face—hopefully you can find a local&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2121"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/#post-1198" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">fe9bf04f312eb2948eb1e00af7b776e0</guid>
				<title>Roberto Ramón Vallarino posted an update: </title>
				<link>https://members.issca.com/news-feed/p/2107/</link>
				<pubDate>Sun, 22 Mar 2026 20:05:07 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d4fb00a425661fe2026577c7238ea0fd</guid>
				<title>Roberto Ramón Vallarino started the discussion Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues. in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/</link>
				<pubDate>Sun, 22 Mar 2026 19:52:45 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/">Clinical Case for Cellular Therapy in Panama: Looking for International collaboration with colleagues.</a></p> <div class="bb-content-inr-wrap"><p>Hello everyone, </p>
</p>
<p>Roberto Vallarino <em>M.D.</em></p>
</p>
<p>Physician from Panama city, Panama. Great to have a community to bring up questions and discussion. Very thankful for responses.</p>
</p>
<p>Ive had 2 years of Regenerative Medicine practice. </p>
</p>
<p>Currently with a upcoming case of autoimmune hep (confirmed), concomitant ulcerative colitis &amp; graves disease </p>
</p>
<p>My patient is a&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-2099"><a href="https://members.issca.com/groups/issca-community/forum/discussion/clinical-case-for-cellular-therapy-in-panama-looking-for-international-collaboration-with-colleagues/" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d60328437a0cfdabb1e06af4cfac7cb8</guid>
				<title>Estefania Rodriguez started the discussion Stem cells vs exosomes in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/</link>
				<pubDate>Fri, 13 Mar 2026 16:09:53 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/stem-cells-vs-exosomes/">Stem cells vs exosomes</a></p> <div class="bb-content-inr-wrap"><p>Si tuviéramos que elegir en nuestra práctica clínica una de las dos, que tipo de terapia celular eligirian stem cells o exosomes ?? A cual terapia celular apunta el futuro de la medicina estética ?</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2d7e486fcc6e83e18d830d8e2cf6f596</guid>
				<title>Roberto Ramón Vallarino posted an update: </title>
				<link>https://members.issca.com/news-feed/p/1675/</link>
				<pubDate>Thu, 12 Mar 2026 03:58:35 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d1e7854efb7f753f21bd3ffbdd2cc493</guid>
				<title>ANTONIO FRANCESCO FRANCO posted an update in the group ISSCA Community: Hello everyone,Has anyone here developed or used [&#133;]</title>
				<link>https://members.issca.com/news-feed/p/1672/</link>
				<pubDate>Wed, 11 Mar 2026 22:05:23 -0500</pubDate>

									<content:encoded><![CDATA[<p>Hello everyone,</p>
<p>Has anyone here developed or used a post-operative peptide kit in aesthetic plastic surgery?</p>
<p>Thank you in advance. If yes, could you please share which protocol or combination of peptides you are using?</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">208bc13ea4d4e3f391f910399810a210</guid>
				<title>Roberto Ramón Vallarino posted an update: </title>
				<link>https://members.issca.com/news-feed/p/1663/</link>
				<pubDate>Tue, 10 Mar 2026 23:40:07 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dfd26cee485481025d05a2e24ce68b34</guid>
				<title>Roberto Ramón Vallarino replied to the discussion What is one regenerative protocol that has completely changed your patient outcomes? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/what-is-one-regenerative-protocol-that-has-completely-changed-your-patient-outcomes/#post-975</link>
				<pubDate>Tue, 10 Mar 2026 23:23:35 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-is-one-regenerative-protocol-that-has-completely-changed-your-patient-outcomes/#post-975"><span class="bb-reply-lable">Reply to</span> What is one regenerative protocol that has completely changed your patient outcomes?</a></p> <div class="bb-content-inr-wrap"><p>Optimize the hormonal and metabolic field. Assess nutritional deficiencies and you will find your practice to be objective.</p>
</p>
<p>When these fields are optimal and supplemental deficiencies are being addressed, the therapeutic outcomes are solid. Most regenerative medicine therapies are sinergical: MSCs, exosomes, peptides, light therapy,&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-1662"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-is-one-regenerative-protocol-that-has-completely-changed-your-patient-outcomes/#post-975" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">448bbd5b46a74a04662228029f485feb</guid>
				<title>Roberto Ramón Vallarino replied to the discussion What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-974</link>
				<pubDate>Tue, 10 Mar 2026 23:19:49 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-974"><span class="bb-reply-lable">Reply to</span> What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice?</a></p> <div class="bb-content-inr-wrap"><p>Im sure that in order to establish Regenerative Medicine in its imminent position; the regulatory aspect of everything represents a challenge. </p>
</p>
<p>What works for me is to be as clear as possible regarding the biological agent I use, the patient must know the evidence as it stands at the day and must know that there are moments/instances were we&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-1661"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-974" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7f8311c3d910a4b6b20b43226152f062</guid>
				<title>Andrea Lapeire replied to the discussion What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-973</link>
				<pubDate>Tue, 10 Mar 2026 19:39:47 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-973"><span class="bb-reply-lable">Reply to</span> What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice?</a></p> <div class="bb-content-inr-wrap"><p>Hace tiempo atrás el primer desafío era encontrar un buen protocolo, después había que educar al paciente, cuando el paciente estaba convencido&#8230; había que decirle el precio! Era una batalla sin fin. Cuando por fin los pacientes venían directamente a preguntar por Regenerativa&#8230; un influencer lo convenció de que lo ideal sería colocar 1&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-1658"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-973" rel="nofollow"> Read more</a></span></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">51ae27406e1c0ea8e0903bb7302c5d8c</guid>
				<title>Emiliano Herrera replied to the discussion What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-971</link>
				<pubDate>Tue, 10 Mar 2026 14:55:20 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/#post-971"><span class="bb-reply-lable">Reply to</span> What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice?</a></p> <div class="bb-content-inr-wrap"><p>I’ve seen the lack of standardized protocols.</p>
<p>There are a lot of influencers and coaches just dosing what they heard from a viral video</p></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">cf7203c332c0934846814106be34dc8c</guid>
				<title>raeya munro started the discussion What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/</link>
				<pubDate>Tue, 10 Mar 2026 14:50:11 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-was-the-hardest-part-of-introducing-regenerative-medicine-into-your-practice/">What Was the Hardest Part of Introducing Regenerative Medicine Into Your Practice?</a></p> <div class="bb-content-inr-wrap"><p>For doctors who have already integrated regenerative medicine into their practice — what was the biggest challenge in the beginning?</p>
</p>
<p>• Patient education</p>
<p>• Pricing</p>
<p>• Training</p>
<p>• Clinical protocols</p>
</p>
<p>Curious to hear your experience.</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">9b21726b5644b2dd104638e4fc50fec6</guid>
				<title>raeya munro started the discussion Whats the most underrated tool in regenerative medicine right now? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/</link>
				<pubDate>Tue, 10 Mar 2026 14:46:04 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/whats-the-most-underrated-tool-in-regenerative-medicine-right-now/">Whats the most underrated tool in regenerative medicine right now?</a></p> <div class="bb-content-inr-wrap"><p>There are a lot of exciting technologies emerging in regenerative medicine.</p>
</p>
<p>In your opinion, what’s the most underrated tool or therapy that more practitioners should be paying attention to right now?</p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a1f003b84c55ae669a0108cae858d682</guid>
				<title>raeya munro started the discussion What is one regenerative protocol that has completely changed your patient outcomes? in the forum ISSCA Community</title>
				<link>https://members.issca.com/groups/issca-community/forum/discussion/what-is-one-regenerative-protocol-that-has-completely-changed-your-patient-outcomes/</link>
				<pubDate>Tue, 10 Mar 2026 14:44:02 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://members.issca.com/groups/issca-community/forum/discussion/what-is-one-regenerative-protocol-that-has-completely-changed-your-patient-outcomes/">What is one regenerative protocol that has completely changed your patient outcomes?</a></p> <div class="bb-content-inr-wrap"><p>Every practitioner develops a protocol that changes the game for their patients.</p>
</p>
<p>What’s one regenerative protocol (PRP, exosomes, peptides, biologics, etc.) that significantly improved your outcomes?</p>
</p>
<p>What made the difference?</p></p>
</div>]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">611d9e28ee845288e6c2d566a418afab</guid>
				<title>Liliana Cimino joined the group ISSCA Community</title>
				<link>https://members.issca.com/news-feed/p/11/</link>
				<pubDate>Sat, 29 Nov 2025 13:45:48 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c464061be74ba07db2720cd5274513aa</guid>
				<title>Liliana Cimino became a registered member</title>
				<link>https://members.issca.com/news-feed/p/9/</link>
				<pubDate>Sat, 29 Nov 2025 12:40:23 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a34ad214e7578218cd5869551a5e0302</guid>
				<title>ISSCA KAhan created the group ISSCA Community</title>
				<link>https://members.issca.com/news-feed/p/5/</link>
				<pubDate>Mon, 17 Nov 2025 05:39:20 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
		